These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7870664)

  • 1. Effect of renal or hepatic dysfunction on neurotoxic convulsion induced by ranitidine in mice.
    Shimokawa M; Yamamoto K; Kawakami J; Sawada Y; Iga T
    Pharm Res; 1994 Nov; 11(11):1519-23. PubMed ID: 7870664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of renal failure on neurotoxicity of ranitidine in rats.
    Nakada Y; Yamamoto K; Kawakami J; Sawada Y; Iga T
    Biol Pharm Bull; 1996 Feb; 19(2):323-5. PubMed ID: 8850334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxic convulsions induced by histamine H2 receptor antagonists in mice.
    Shimokawa M; Yamamoto K; Kawakami J; Sawada Y; Iga T
    Toxicol Appl Pharmacol; 1996 Feb; 136(2):317-23. PubMed ID: 8619239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
    Lin JH
    Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxic convulsions induced by theophylline and its metabolites in mice.
    Yamamoto K; Toyama E; Kawakami J; Sawada Y; Iga T
    Biol Pharm Bull; 1996 Jun; 19(6):869-72. PubMed ID: 8799489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic drug interactions between triamterene and ranitidine in humans: alterations in renal and hepatic clearances and gastrointestinal absorption.
    Muirhead M; Bochner F; Somogyi A
    J Pharmacol Exp Ther; 1988 Feb; 244(2):734-9. PubMed ID: 3346844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of drug action in disease states. XIX. Effect of experimental liver disease on the neurotoxicity of theophylline in rats.
    Ramzan IM; Yasuhara M; Levy G
    J Pharmacol Exp Ther; 1987 Apr; 241(1):236-8. PubMed ID: 3494838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of drug action in disease states. XVIII. Effect of experimental renal failure on the pharmacodynamics of theophylline-induced seizures in rats.
    Ramzan IM; Levy G
    J Pharmacol Exp Ther; 1987 Feb; 240(2):584-8. PubMed ID: 3806413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Convulsive liability of an oral carbapenem antibiotic, tebipenem pivoxil].
    Yagi Y; Nawa T; Kurata Y; Shibasaki S; Suzuki H; Kurosawa T
    Jpn J Antibiot; 2009 Jun; 62(3):241-52. PubMed ID: 19882983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Brain Pharmacokinetic and Neuropharmacodynamic Attributes of an Antiepileptic Drug, Lacosamide, in Hepatic and Renal Impairment: Preclinical Evidence.
    Kumar B; Modi M; Saikia B; Medhi B
    ACS Chem Neurosci; 2017 Jul; 8(7):1589-1597. PubMed ID: 28324653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acute renal failure on neurotoxicity of cimetidine in rats.
    Nakada Y; Yamamoto K; Kawakami J; Sawada Y; Iga T
    Pharm Res; 1995 Dec; 12(12):1953-7. PubMed ID: 8786972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of histamine and the h2 receptor antagonist ranitidine on ischemia-induced acute renal failure: involvement of IL-6 and vascular endothelial growth factor.
    Vannay A; Fekete A; Müller V; Strehlau J; Viklicky O; Veres T; Reusz G; Tulassay T; Szabó AJ
    Kidney Blood Press Res; 2004; 27(2):105-13. PubMed ID: 15031602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine as an inhibitor of liver regeneration.
    Kanashima R; Nagasue N; Sakato K
    Am J Surg; 1985 Feb; 149(2):223-7. PubMed ID: 3970320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications.
    Powell JR; Donn KH
    J Clin Gastroenterol; 1983; 5 Suppl 1():95-113. PubMed ID: 6140286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of ranitidine in renal impairment.
    Koch KM; Liu M; Davis IM; Shaw S; Yin Y
    Eur J Clin Pharmacol; 1997; 52(3):229-34. PubMed ID: 9218931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of new quinolones on GABA(A) receptor-mediated response and its potentiation with felbinac in Xenopus oocytes injected with mouse-brain mRNA: correlation with convulsive potency in vivo.
    Kawakami J; Yamamoto K; Asanuma A; Yanagisawa K; Sawada Y; Iga T
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):246-54. PubMed ID: 9266796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
    Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
    Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cimetidine and ranitidine on cardiovascular drugs.
    Baciewicz AM; Baciewicz FA
    Am Heart J; 1989 Jul; 118(1):144-54. PubMed ID: 2662728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and histological studies on H2-receptor antagonist ranitidine-induced hepatotoxicity in rats.
    Hemieda FA; Abdel-Hady el-SK; Elnga MA
    Indian J Exp Biol; 2005 Sep; 43(9):782-5. PubMed ID: 16187528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of drug action in disease states. XXXIII: Disparate effects of pentylenetetrazol in rats as a function of renal disease model and pharmacologic endpoint.
    Ramzan I; Levy G
    J Pharm Sci; 1989 Feb; 78(2):142-5. PubMed ID: 2715936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.